Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools
PeerASMAS
1 other identifier
interventional
243
1 country
1
Brief Summary
Health disparities in pediatric asthma persist, with Latino children demonstrating increased asthma morbidity. Middle school children with asthma have greater morbidity than children from any other age group and spend a majority of their day in school, where they must manage any asthma. The investigators developed and piloted a novel group-based intervention - ASMAS (Asthma Self-MAnagement in Schools) in two geographic areas with a high prevalence of urban and Latino children with asthma: Providence, Rhode Island, and San Juan, Puerto Rico. ASMAS is a 4-session, peer-facilitated asthma self-management intervention specific to the school setting for Latino middle school (6th-8th graders) children. It is delivered by trained High School Juniors and Seniors of Latino descent with asthma. The preliminary effects of ASMAS for improving asthma outcomes and self-management relative to controls were demonstrated in a previous intervention development study. This study will evaluate ASMAS through a large-scaled Randomized Control Trial with urban middle school students who have persistent asthma in Providence, Rhode Island and San Juan, Puerto Rico and will identify barriers and facilitators to the implementation of ASMAS. These results will inform future, large-scale dissemination in other urban school settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable asthma
Started Apr 2019
Longer than P75 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2018
CompletedFirst Posted
Study publicly available on registry
February 26, 2018
CompletedStudy Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2024
CompletedSeptember 27, 2024
September 1, 2024
5.2 years
January 24, 2018
September 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Change in asthma control
Assessed by child and parent report through the 7-item Child Asthma Control Test (C-ACT)
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in symptom free days
By parent report using standard questionnaire of symptom-free days/nights in prior 30 days
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in asthma related school absence ratio
Asthma related school absence ratio will be calculated from school attendance data and caregiver report of school absences due to asthma
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in lung function
The Asthma Monitor 2 (AM2, ERT, USA) is a hand-held, computerized spirometer that collects pulmonary function indexes (Forced Expiratory Volume at one second, FEV1 ). Children will use AM2 during one week using standard procedures, 2x/day (before medications AM/PM). FEV1 predicted will be obtained.
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Secondary Outcomes (4)
Change in child asthma knowledge
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in child asthma self-efficacy
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in asthma self-management
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Change in asthma Action plan/Inhaler availability
Assessed at baseline, immediately post intervention, and 4 months post intervention , 8 months post intervention, and 12-months post intervention
Study Arms (3)
ASMAS
EXPERIMENTALASMAS is an asthma self-management program based on NHLBI clinical guidelines for optimal school-based asthma management. It involves 4, 1½ hour sessions delivered in group format in the urban, middle school setting by a Latino High School Peer who has asthma. ASMAS focuses on asthma pathophysiology, symptom management, asthma medications, and trigger control.
Asthma education plus child health
ACTIVE COMPARATORAsthma Education plus Child Health control condition will be delivered by an adult Health Educator , and includes 4 sessions (1 1/2 hrs long) of our existing asthma education ("Asthma's Magic Number") with added general health topics (nutrition, physical activity, safety).
No Treatment Control
NO INTERVENTIONStudents randomly assigned to this arm , will receive standard of care, which is no treatment, and will not participate in any group intervention sessions.
Interventions
A high school peer led group intervention for middles school students targeting asthma education and asthma management practices.
Health educator led intervention focused on asthma education and other child health topics.
Eligibility Criteria
You may qualify if:
- Be 11-14 years old
- Attend 6th, 7th or 8th grade
- attend a targeted public school
- have physician-diagnosed asthma according to caregiver and provider report
- meet criteria for current persistent asthma either by a) having a current prescription for an asthma controller medicine, or b) having any of the following in the previous 4 weeks:
- I. daytime asthma symptoms \> 2 days/week,
- II. nighttime awakenings due to asthma at least 3-4 times/month,
- III. short-acting beta agonist use at least 2 days/week,
- IV. activity limitation, or
- V. oral steroid use at least 2 times/year
- children must have recent active asthma activity in the previous 4 weeks through endorsement of any of criteria I-V above
- In Rhode Island, children's primary caregiver must identify as Latino
- In Rhode Island, children must speak English
You may not qualify if:
- active immunotherapy,
- other pulmonary disease,
- receiving special education services in a self-contained classroom,
- any severe psychiatric or medical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rhode Island Hospitallead
- University of Puerto Ricocollaborator
Study Sites (1)
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Daphne Koinis-Mitchell, PhD
Rhode Island Hospital
- PRINCIPAL INVESTIGATOR
Glorisa Canino, PhD
University of Puerto Rico
- STUDY DIRECTOR
Sheryl J Kopel, MSc
Rhode Island Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2018
First Posted
February 26, 2018
Study Start
April 1, 2019
Primary Completion
May 31, 2024
Study Completion
May 31, 2024
Last Updated
September 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share